Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules.
Stephen M RaoRachel GaliotoM SokolowskiM McGinleyJ FreiburgerM WeberT DeyL MouranyD SchindlerC ReeceD M MillerF BethouxR A BermelJ R WilliamsN LevittG A PhillipsJ K RhodesJ AlbertsR A RudickPublished in: European journal of neurology (2020)
The self-administered MSPT neuroperformance modules produce reliable, objective metrics that can be used in clinical practice and support outcomes research. Published studies which require patient voluntary consent may underestimate the rate of cognitive dysfunction observed in a clinical setting.